Month: October 2022

2022/10 Cyfuse reports progress on 3D printed organoids

https://bio.nikkeibp.co.jp/atcl/news/p1/22/10/27/10073/ https://en.cyfusebio.com Cyfuse was established in 2010 and is focused on 3D cell technology that uses a bio 3D printer to laminate cell clumps (spheroids) consisting of an average of 10,000 cells in a 3D manner without the use of artificial scaffolds. The company has 3 business fields: to develop a pipeline of regenerative medicine […]

Cyfuse raises about 13 million € for 3D printed organoids

https://bio.nikkeibp.co.jp/atcl/news/p1/22/10/27/10073/ https://en.cyfusebio.com Cyfuse was established in 2010 and is focused on 3D cell technology that uses a bio 3D printer to laminate cell clumps (spheroids) consisting of an average of 10,000 cells in a 3D manner without the use of artificial scaffolds. The company has 3 business fields: to develop a pipeline of regenerative medicine […]

Stretchable and self-healing polymer gels formed by a facile one-step synthesis

https://www.science.org/doi/10.1126/sciadv.add0226 Researchers at the National Institute for Material Sciences have formed highly stretchable and self-healing polymer gels solely by physical entanglements of ultrahigh–molecular weight (UHMW) polymers fabricated through a facile one-step process. Radical polymerization of vinyl monomers in ionic liquids under very low initiator concentration conditions produced UHMW polymers of more than 106 g/mol with […]

Osaka University will establish “digital twin” for human organ interactions

https://bio.nikkeibp.co.jp/atcl/news/p1/22/10/14/10030/ https://www.youtube.com/watch?v=unvKIcKTBuY Osaka University’s “Human Metabolic Disease Research Center” will establish a “digital twin” for organoids  created mainly from iPS cells, and their diseases.  The response of organoids to disease states will be comprehensively investigated using multi-omics analysis, single-cell analysis, quantum sensing, The bio-digital twins created will be shared by constructing a new metaverse space. The […]

Advances in diabetes-1 treatment by cell technology

https://bio.nikkeibp.co.jp/atcl/report/16/082400016/100500253/ The group around Tetsuya Ikemoto, a GI surgeon at the University Hospital of Fukushima, prepares for an investigator-initiated clinical trial on insulin-producing cells (IPC) derived from autologous fat cells of human patients. He has finished safety evaluation and proof-of-concept experiments using diabetic mice and pigs. The insulin-producing cells under study are adipose-derived stem cells taken […]

Scroll to top